AF makes some points, but fails to explain that the lower rev forecasts are likely due to a delay in recognizing the French revs, about $15-20MM, now shifted from 2014 into 2015. That of course will bring that $20MM into 2015, so that 2015 number is hardening, i.e. likely to be good (I need to revisit the math but $150's is not impossible. The 15mg price fix and the good Rx numbers will help quite a bit.
The 15mg fix will be a bit more complicated to achieve in Eu though.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.